Teladoc Health (NYSE:TDOC) Announces Earnings Results, Misses Estimates By $0.07 EPS

Teladoc Health (NYSE:TDOC) issued its earnings results on Wednesday. The health services provider reported ($0.28) EPS for the quarter, missing the consensus estimate of ($0.21) by ($0.07), Zacks reports. Teladoc Health had a negative net margin of 37.91% and a negative return on equity of 10.06%. Teladoc Health updated its Q1 2025 guidance to -0.400–0.150 EPS and its FY 2025 guidance to -1.100–0.500 EPS.

Teladoc Health Stock Performance

TDOC traded down $0.28 during trading hours on Wednesday, reaching $10.91. The company’s stock had a trading volume of 10,340,108 shares, compared to its average volume of 8,008,443. The company’s 50-day moving average is $10.58 and its 200-day moving average is $9.52. Teladoc Health has a 52 week low of $6.76 and a 52 week high of $15.95. The firm has a market cap of $1.88 billion, a PE ratio of -1.89 and a beta of 1.04. The company has a debt-to-equity ratio of 0.66, a quick ratio of 1.69 and a current ratio of 1.73.

Analyst Ratings Changes

Several brokerages recently commented on TDOC. The Goldman Sachs Group raised their price objective on Teladoc Health from $14.00 to $16.00 and gave the stock a “buy” rating in a research note on Tuesday, February 18th. Piper Sandler reiterated an “overweight” rating and set a $13.00 price objective (up previously from $11.00) on shares of Teladoc Health in a report on Wednesday, December 4th. Royal Bank of Canada increased their target price on Teladoc Health from $11.00 to $12.00 and gave the stock an “outperform” rating in a research note on Friday, January 24th. Deutsche Bank Aktiengesellschaft upped their price target on shares of Teladoc Health from $10.00 to $12.00 and gave the company a “hold” rating in a report on Friday, November 1st. Finally, TD Cowen lowered their price objective on shares of Teladoc Health from $9.00 to $8.00 and set a “hold” rating for the company in a research report on Thursday, October 31st. Thirteen analysts have rated the stock with a hold rating and seven have issued a buy rating to the company’s stock. According to data from MarketBeat.com, the stock presently has a consensus rating of “Hold” and a consensus price target of $11.81.

Insider Buying and Selling at Teladoc Health

In other news, insider Carlos Nueno sold 2,389 shares of the business’s stock in a transaction that occurred on Monday, December 2nd. The stock was sold at an average price of $11.93, for a total transaction of $28,500.77. Following the completion of the sale, the insider now owns 2,890 shares in the company, valued at $34,477.70. The trade was a 45.25 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is available at this hyperlink. Corporate insiders own 0.95% of the company’s stock.

Teladoc Health Company Profile

Teladoc Health, Inc provides virtual healthcare services worldwide. The company operates through Teladoc Health Integrated Care and BetterHelp segments. The Integrated Care segment offers virtual medical services, including general medical, expert medical, specialty medical, chronic condition management, and mental health, as well as enabling technologies and enterprise telehealth solutions for hospitals and health systems.